WAXMAN STRATEGIES

Lobbying for 340B HEALTH · advocacy and membership organization

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $39,000.00 income · posted Jan 13, 2026

Lobbying activity 2

Health Issues

Issues affecting the 340B drug pricing program; Appropriations for 340B program.

Pharmacy

Issues affecting the 340B drug pricing program; Appropriations for 340B program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.